chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: VARZOS
Symptoms: Injection site rash
Clinical narrative: Information has been received from a female consumer, reporting on herself, who on 20-MAY-2011 was vaccinated with a dose of ZOSTAVAX (Merck) (lot #, dose and route not reported). Consumer reported that, on an unknown date, she developed a rash at the injection site. It was unknown if patient sought medical attention. At the time of the report, the patient's outcome was not recovered. Additional information is not expected.
Sex: F
Vaccine: VARZOS
Symptoms: Trichorrhexis
Clinical narrative: Information has been received from a female consumer, reporting on herself, who in August 2010, was vaccinated with a dose of ZOSTAVAX (Merck) (Lot #, dose and route not reported). Consumer reported that the next day after receiving the vaccine she had a perm done on her hair and that her hair had been breaking off since then. It was unknown if patient sought medical attention. At the time of the report the patient's outcome was not recovered. Additional information has been requested.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site warmth
Clinical narrative: Information has been received from a 61 year old female consumer reporting on herself with no pertinent medical history who on 18-MAY-2011 was subcutaneously vaccinated with one dose of 0.65 mL of ZOSTAVAX (Merck (Lot# and expiration not reported). Concomitant therapy included LIPITOR and LEXAPRO. Consumer reported that on 18-MAY-2011 had injection site reactions. She stated that she had a bad injection site reaction. It was red, painful, hot and itchy. The consumer also stated that when she was given the injection it hurt really badly. The consumer noted that the redness was gone down but the itchiness had not. No laboratories were performed. The patient sought medical attention by a call to the pharmacy. "AVEENO" and ice were given as treatment for the adverse event. At the time of reporting the patient had not recovered. No further information is available.
Age: 68.0
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from an office manager concerning a 70 year old male patient with no allergies or drug reactions, diabetes, hypertension, hyperlipidaemia, benign prostatic hypertrophy, degenerative joint disease, ischaemic heart disease and chronic obstructive pulmonary disease who on 16-OCT-2009 was vaccinated with a dose of 0.65 mL of ZOSTAVAX (Merck) (Lot # and expiration not reported). Concomitant therapy included ZYLORIC, SIMCOR, AVANDAMET, HCTZ/triamterene, naproxen and NORVASC. The office manager reported that on 20-MAY-2011 the patient developed shingles blisters on his left chest wall to the back. No laboratories were performed. The patient sought unspecified medical attention. As treatment the patient received VALTREX 1mg twice daily, "CALADRYL" lotion three times daily and an unspecified paid medication. At the time of reporting the patient had not recovered. Additional information has been requested.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a consumer concerning his 69 year old wife with arthritis who on 02-OCT-2009 was vaccinated with a dose of ZOSTAVAX (Merck). On 31-MAY-2010 the patient experienced a case of shingles. The patient received unspecified medical attention. The patient's shingles persisted. Additional information has been requested.
Age: 78.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site rash
Clinical narrative: Information has been received from a pharmacist concerning a 78 year old female who on 24-MAY-2010 was vaccinated with ZOSTAVAX (Merck) (route and injection site not reported). The patient has had an injection site rash since it was given on 24-MAY-210. The patient did not seek medical attention. At the time of reporting, the patient's injection site rash persisted. Additional information has been requested.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Information has been received from a office manager concerning a 63 year old female with no medical history or drug reactions/allergies who on 21-MAY-2010 was vaccinated SC with a 0.65 ml ZOSTAVAX (Merck) (lot # 665430/1764Y, expiration 15-MAR-2011). Concomitant therapy included a hormone replacement therapy (therapy unspecified). On approximately 21-MAY-2010 (within 24 hours of being vaccinated) the patient developed redness and swelling in an area of 6 inches at the injection site. The patient called office to seek medical attention. The patient was prescribed DOXYCLIN. There was no laboratory test performed. Subsequently on an unspecified date the patient recovered. Additional information has been requested.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site swelling
Clinical narrative: Information has been received from  62 year old female patient with no pertinent medical history or drug reactions who 2 days ago (26-MAY-2010) was vaccinated with a dose of ZOSTAVAX (Merck). Concomitant therapy included KEFLEX. On 27-MAY-2010 (yesterday), the patient experienced redness and swelling at the injection site after receiving ZOSTAVAX (Merck). The patient sought medical attention via office visit. No laboratory diagnostics studies were performed. At the time of this report, the patient had not recovered. Additional information has been requested.
Age: 55.0
Sex: M
Vaccine: VARZOS
Symptoms: Dermatitis contact, Drug administered to patient of inappropriate age
Clinical narrative: Information has been received from a current 56 year old male patient with a history of shingles (two cases) who at the age of 55 on 05-JUN-2009 was vaccinated with a dose of ZOSTAVAX (Merck) (Lot # not reported). The patient reported that on 04-JUN-2010 experienced a case of shingles. The patient called back and reported that he went to a dermatologist who verified that he had poison ivy and no shingles. At the time of the report, the patient had not recovered. Additional information has been requested.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Burning sensation, Dyspepsia, Facial pain, Herpes zoster, Hypoaesthesia eye
Clinical narrative: Information has been received from a 65 year old female patient with allergic reaction to LEVAQUIN and no other pertinent medical history who in April 2010, was vaccinated with a 0.65 ml dose of ZOSTAVAX (Merck). There was no concomitant medication. About a week after receiving ZOSTAVAX (Merck), the patient developed a fever blister on her lip. Then about three to four weeks ago the patient had itching, tingling, burning, or painful feeling starting from the corner of her right eye down to her chin. Then about two or three days after that, the patient developed one big bump in the middle of her cheek along with a few small bumps. The patient went to see her physician and from what she was describing, they thought the patient had the shingles so they give her acyclovir (manufacturer unknown) and prednisone (manufacturer unknown). The patient reported that she still had a numbing feeling that went from her pupil to the corner of her eye. The patient reported that she was going to see her eye doctor. The patient also reported while taking acyclovir (manufacturer unspecified), she had a burning sensation in the upper part of her stomach. No laboratory diagnostics studies were performed. At the time of the report, the patient was not recovered. No further information is available.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Oral herpes, Paraesthesia, Pruritus, Rash
Clinical narrative: Information has been received from a 65 year old female patient with allergic reaction to LEVAQUIN and no other pertinent medical history who in April 2010, was vaccinated with a 0.65 ml dose of ZOSTAVAX (Merck). There was no concomitant medication. About a week after receiving ZOSTAVAX (Merck), the patient developed a fever blister on her lip. Then about three to four weeks ago the patient had itching, tingling, burning, or painful feeling starting from the corner of her right eye down to her chin. Then about two or three days after that, the patient developed one big bump in the middle of her cheek along with a few small bumps. The patient went to see her physician and from what she was describing, they thought the patient had the shingles so they give her acyclovir (manufacturer unknown) and prednisone (manufacturer unknown). The patient reported that she still had a numbing feeling that went from her pupil to the corner of her eye. The patient reported that she was going to see her eye doctor. The patient also reported while taking acyclovir (manufacturer unspecified), she had a burning sensation in the upper part of her stomach. No laboratory diagnostics studies were performed. At the time of the report, the patient was not recovered. No further information is available.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Rash
Clinical narrative: Information has been received from a pharmacist concerning a 66 year old female patient with no pertinent medical history who on 06-JUN-2010 was vaccinated with a 0.65 ml dose of ZOSTAVAX (Merck). On 07-JUN-2010 the pharmacist called the patient to check on her and the patient stated that the injection site was a little red and she had a rash on her chest that was the size of a hand, but it's not itchy, spreading or raised. It was reported the patient did not seek any medical attention. No laboratory diagnostics studies were performed. At the time of the report, the patient was not recovered. Follow up information was received from the pharmacist concerning a 65 year old (previous reported as 66 year old) retired female patient who on 06-JUN-2010 at 13:00, was vaccinated with the first 0.65 ml dose of ZOSTAVAX (Merck) (lot # 664636/0847Y) SC into the right side. There was no illness at time of vaccination. On 07-JUN-2010 at 08:00 ("one day after vaccine"), the patient developed a self-limiting rash on her chest and neck. On 09-JUN-2010, the patient was recovered. The patient did not seek medical attention. Additional information has been requested.
Age: 81.0
Sex: F
Vaccine: VARZOS
Symptoms: Blister, Expired drug administered, Rash vesicular
Clinical narrative: Information has been received from a pharmacist concerning an 81 year old female who on 05-MAY-2010 was vaccinated with a dose of ZOSTAVAX (Merck) (lot # 664628/1018Y, exp 16-JAN-2010), 18 days after vaccination, on 23-MAY-2010 the patient experienced a chickenpox like rash on her upper arms. There were pink fluid filled blisters. The patient would see her physician and then considered the VZV program. There were no lab diagnostics studies performed. At the time of the report, the patient had not recovered. Additional information has been requested.
Age: 83.0
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a nurse concerning her 83 year old father who on an unspecified date was vaccinated with a dose of ZOSTAVAX (Merck). Two to three months ago the patient got shingles on his back. The patient had sought unknown medical attention. At the time of report the patient's status was unknown. No further information is available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a patient who in approximately 2008, "about two years ago", was vaccinated with a dose of ZOSTAVAX (Merck). Subsequently the patient experienced shingles all over the right side of face, ear and hair. It was unknown if the patient sought medical attention. At the time of the report, the outcome of the patient was unknown. It was also mentioned that the patient was vaccinated with ZOSTAVAX (Merck) because the patient's mother had shingles. Additional information is not expected.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Condition aggravated, Culture, Fatigue, Herpes zoster
Clinical narrative: Information has been received from a 65 year old female nurse practitioner concerning herself with lupus, multiple mini strokes, rheumatoid arthritis, basel cell carcinoma, rectal polyp, CLARITIN reaction (hives from head to foot) and a history of fatty tumor removed from left arm, migraines, compartment syndrome, and shingles prior to 2008 who in 2008, was vaccinated with a dose of ZOSTAVAX (Merck) (dose reported as 0.65). Concomitant therapy included gabapentin, PLAVIX, labetalol HCl, quinapril HCl, amlodipine and zolpidem tartrate. On 07-APR-2009, the patient experienced shingles. It reported that the patient experienced shingles 3 or 4 times since receiving the vaccine, and the last two times being in December 2009 and March 2010. Each outbreak was the same. Cultures on the sore from the actual breakout were performed (result not provided). At the time of reporting, the patient was recovering. The patient sought unspecified medical attention. The patient also reported that when taking gabapentin, she got very tired. The medications (unspecified) she had used for rheumatoid arthritis had not helped her. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Injection site rash
Clinical narrative: Information has been received from a Registered Nurse reporting that a physician from another practice called her office and reported that one of the physician's patients on an unspecified date, was vaccinated with a dose of ZOSTAVAX (Merck) (lot# not reported). The patient developed a rash at the injection site about two weeks after receiving ZOSTAVAX (Merck). At the time of reporting, the outcome of the event was not reported. The patient sought medical attention via contacting office. The nurse did not speak to the physician and did not have any other information about the patient, rash or physician. VZV packed was not faxed to the office. No further information is available.
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site irritation, Injection site swelling
Clinical narrative: Information has been received from a physician concerning a female patient about "50 to 59 years of age" who on an unspecified date, was vaccinated with a 0.65 ml dose of ZOSTAVAX (Merck) (lot# and dose not reported). The physician reported that the patient had an injection site reaction on ZOSTAVAX (Merck). On an unspecified date, the patient had a lot of irritation and swelling around the injection site. The physician stated that the patient had never had that happened before and the patient was not worried about it since it resolved on its own. The physician also showed her the product information (PI). No labs/diagnostics studies were performed. The patient just called into the office, and the physician did not think that the patient was even seen. No further information is available.
Age: 40.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Injection site erythema, Injection site reaction, Injection site warmth, Oedema peripheral
Clinical narrative: Information has been received from a 40 year old female patient with neuropathy, depression, thyroid problem and stomach problem and who was allergic to aspirin, erythromycin, clindamycin; some food allergies as oysters and allergic to pollen; who "last Wednesday" (on 13-APR-2011) was vaccinated at the back of the right arm with a dose of ZOSTAVAX (Merck) (lot# not specified). Concomitant therapy included NEURONTIN, Mirtazapine (MSD), levothyroxine Na and "Platonix". The patient reported that the same afternoon after receiving the dose of ZOSTAVAX (Merck) (on 13-APR-2011), she experienced injection site reaction. Her right arm became swollen and really puffy, was itchy and red hot to touch. She stated she showed her Dad, who was pharmacist, and he told her to use cortisone cream (unspecified). The patient stated her arm was still swollen but she thought the cream was starting to help since the swelling had decreased somewhat, and the site was not as hot. She stated that she still had a ring of red at the site. No lab diagnostic studies were performed. Follow up information has been received from a female business staff from the physician's office who stated that original patient's adverse event could not be located. She had no new information about the patient's adverse event. She also stated the patient did not get ZOSTAVAX (Merck) in the physician's office. No further information is available.
Age: 40.0
Sex: F
Vaccine: VARZOS
Symptoms: Pruritus, Skin warm
Clinical narrative: Information has been received from a 40 year old female patient with neuropathy, depression, thyroid problem and stomach problem and who was allergic to aspirin, erythromycin, clindamycin; some food allergies as oysters and allergic to pollen; who "last Wednesday" (on 13-APR-2011) was vaccinated at the back of the right arm with a dose of ZOSTAVAX (Merck) (lot# not specified). Concomitant therapy included NEURONTIN, Mirtazapine (MSD), levothyroxine Na and "Platonix". The patient reported that the same afternoon after receiving the dose of ZOSTAVAX (Merck) (on 13-APR-2011), she experienced injection site reaction. Her right arm became swollen and really puffy, was itchy and red hot to touch. She stated she showed her Dad, who was pharmacist, and he told her to use cortisone cream (unspecified). The patient stated her arm was still swollen but she thought the cream was starting to help since the swelling had decreased somewhat, and the site was not as hot. She stated that she still had a ring of red at the site. No lab diagnostic studies were performed. Follow up information has been received from a female business staff from the physician's office who stated that original patient's adverse event could not be located. She had no new information about the patient's adverse event. She also stated the patient did not get ZOSTAVAX (Merck) in the physician's office. No further information is available.
Age: 88.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site swelling, Laboratory test
Clinical narrative: Information has been received from a consumer reporting on herself an 88 year old female with no allergies or drug reactions reported who on 12-APR-2011, was vaccinated with a dose of ZOSTAVAX (Merck) on the left arm (route and lot number not reported). Concomitant therapy included vitamins (unspecified) and lovastatin (manufacturer unknown). On 13-APR-2011, the consumer reported that experienced swelling on her left arm at the injection site. The patient sought medical attention by referred to Health care professional. The patient was treated with antihistamine. On 14-APR-2011, laboratories were performed (no results were provided). At the time of the report the outcome of the patient was unknown. Additional information has been requested.
Age: 80.0
Sex: M
Vaccine: VARZOS
Symptoms: Headache, Insomnia
Clinical narrative: Information has been received from an 80 year old male with tinnitus who on 18-APR-2011 was vaccinated with a dose of ZOSTAVAX (Merck) (lot # not reported). There was no concomitant medication. The reporter stated that he last night ("18-APR-2011") started to experience headache and trouble sleeping. The patient had made an appointment with his HCP regarding the effects he experienced after having been vaccinated with ZOSTAVAX (Merck). No treatment was given for adverse events. At the time of reporting, the outcome of the patient was unknown. The patient did not seek medical attention. Additional information has been requested.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: Information has been received from a registered pharmacist concerning a 64 year old female patient with hypertension and penicillin allergy who on 18-APR-2011 was vaccinated subcutaneously in the left arm, with a dose of 0.65 ml ZOSTAVAX (Merck) (Lot #: 669263/1361Z, Exp: 15-JAN-2012). There was no concomitant medication. The pharmacist reported that when the patient removed the band-aid over the injection site, she noticed a small red area at the site underneath the band-aid where she received the injection. Pharmacist was told by the patient that on 20-APR-2011, she noticed that the small red area was larger. The patient went to the pharmacy on 21-APR-2011 and pharmacist reported that the area was hard, raised, warm to the touch and it was two to three inches in size. No treatment was given for the events. No lab/diagnostic studies were performed. At the time of the report, the patient's outcome was not recovered. Additional information has been requested.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a physician concerning a 70 year old female patient, who on an unknown date, was vaccinated with a dose of ZOSTAVAX (Merck) (lot #, dose and route not reported). Physician reported that patient came out with a case of shingles after receiving the ZOSTAVAX (Merck). It was unknown if the patient sought medical attention. At the time of the report, the patient's outcome was unknown. Additional information has been requested.
Age: 56.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site vesicles
Clinical narrative: Information has been received from a registered pharmacist (R. Ph)concerning a 56 year old female patient with drug allergy to unspecified opioids and no known medical history who on 19-APR-2011, was vaccinated with a dose of ZOSTAVAX (Merck), 0.65 ml, subcutaneously, (lot number not reported). Concomitant therapy included methadone HCl. On 22-APR-2011, the patient called to R. Ph to report that she had broken out in blisters at the injection site, at unspecified time following vaccination. Also, R. Ph reported that the patient reported a single, dime-sized blister surrounded by multiple smaller blisters, which were not painful unless touched. BENADRYL (unspecified dose) was given to treat the blisters. The patient received sought medical attention by a telephone call to pharmacist. No lab test was performed. This is one of several reports received from the same source. At the time of the report, the patient had not recovered. Additional information has been requested.
Age: 52.0
Sex: F
Vaccine: VARZOS
Symptoms: Immediate post-injection reaction, Injection site mass
Clinical narrative: Information has been received from a pharmacist concerning a 52 year old female who on 22-APR-2011 was vaccinated with a dose of ZOSTAVAX 0.65ml in the left deltoid (Merck) (lot#: 669590/1507Z) (Expiration: 02-FEB-2012) and immediately a large lump appeared at the injection site. The patient did not know if it was administered subcutaneously or intradermally. On an unspecified date, the patient sought medical attention via office visit. There was no lab diagnostic performed. At the time or the report, the patient had not recovered. Additional information has been requested.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia
Clinical narrative: Information has been received from a pharmacist concerning a female in her sixties who on approximately 08-APR-2011, "2 weeks ago", was vaccinated with a dose of ZOSTAVAX (Merck) (dose, route and Lot # not reported). On approximately 19-APR-2011, "2-3 days ago", the patient developed pain "behind her knees". The patient called pharmacist to seek medical attention. At the time of the report, the status of the patient was not reported. Additional information has been requested.
Age: 53.0
Sex: F
Vaccine: VARZOS
Symptoms: Drug administered at inappropriate site, Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Information has been received from a registered nurse concerning a 53 year old female patient with ZANTAC and a history of herpes simplex who on 07-APR-2011 was vaccinated SC (in the back of arm rather than the deltoid) with a dose of ZOSTAVAX (Merck) (lot # 665527/0696Z, exp 21-APR-2011). Concomitant therapy included valacyclovir hydrochloride and omega-3 marine triglycerides. On 07-APR-2011 ("that day") the patient developed warmth, swelling, pain and a red area at the injection site. There was no treatment given. There was were no lab diagnostic studies performed. At the time of reporting, she was recovering. The patient sought unspecified medical attention. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Injection site mass
Clinical narrative: Information has been received from a registered pharmacist concerning a patient who on an unspecified date was vaccinated with a dose of ZOSTAVAX (Merck). On an unspecified date the patient experienced a large mass at the injection site the size of a "golf ball" which eventually dissipated. Additional information has been requested. This is one of several reports from the same source.
Sex: U
Vaccine: VARZOS
Symptoms: Injection site rash, Rash vesicular
Clinical narrative: Information has been received from a physician concerning a patient who on an unspecified date was vaccinated with a dose of ZOSTAVAX (Merck). On an unspecified date the patient developed a zoster-like rash at site of injection. The patent sought unspecified medical attention and was given antiviral medication (name unknown) for treatment. Upon the time of the report, the patient's present status was unknown. No further information is available.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a pharmacist concerning a female patient who about one years ago (in 2009) was vaccinated with a dose of ZOSTAVAX (Merck). Subsequently, the patient had shingles on her head extending towards her eye. The patient contacted a physician for medical attention. At the time of the report, the patient had recovered. The patient and her brother in law were both vaccinated by the same physician (WAES#1006USA00017). This is one of several reports received from the same source. Additional information has been requested.
Age: 86.0
Sex: M
Vaccine: VARZOS
Symptoms: Asthenia, Condition aggravated, Gait disturbance, Pyrexia, Tachycardia
Clinical narrative: Information has been received from a registered nurse concerning an 86 year old male with a history of sore throat with a low grade fever in the evening two weeks prior to the day of the injection and a history of chickenpox as child. The patient had no known drug allergy and no recent exposure to chickenpox or shingles. The patient was treated with antibiotics azithromycin once a day for 10 days. The patient finished the antibiotics on 29-JAN-2011. On 02-FEB-2011, at 09:30, the patient was vaccinated with a 0.7 ml dose of ZOSTAVAX (Merck) into his right arm (lot # 669410/1382Z). The nurse reported that the patient reported he began a reaction at approximately 17:30. He developed a marked tachycardia and felt generally weak. These symptoms persisted throughout the evening and the patient reported he probably had a fever. The nurse reported the patient's maximum temperature was 99. The patient was very unsteady on his feet. He found it more comfortable to sit upright in a chair. The patient reported it was so strange and uncomfortable that he considered phoning OPD and 911. Between 2.0 AM and 2:30 am the reaction subsided and the patient slept with no more trouble. The patient stated that he found one report noted certain antibiotics were contraindicated with a shingles injection and his bets were that the reaction was from residual antibiotics in his system. The nurse reported the patient recovered from the events. This is one of several report received from the same source. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a nurse practitioner concerning a patient who on an unspecified date was vaccinated with a dose of ZOSTAVAX (Merck) (lot #, dose and route not reported). The nurse noted hearing "via word-of-mouth" of the patient in another clinic experienced shingles. Attempts are being made to verify the existence of an identifiable patient. Follow-up information has been received via telephone call, from a nurse practitioner, concerning a patient who, on an unknown date received a dose of ZOSTAVAX (Merck) (Lot #, dose and route not reported). The nurse practitioner stated that the patient received the ZOSTAVAX (Merck) at another take care clinic. She also stated that the patient developed shingles after receiving the ZOSTAVAX (Merck). At the time of the report the patient's outcome was unknown. All telephone attempts to obtain follow-up information have been unsuccessful. This is one of several reports from the same source. Additional information has been requested.
Age: 85.0
Sex: M
Vaccine: VARZOS
Symptoms: Cataract operation, Herpes simplex ophthalmic
Clinical narrative: Information has been received from a physician concerning an 85 year old male with age related macular degeneration, normal tension glaucoma and cataracts who received a dose of ZOSTAVAX (Merck) (date not provided). It was reported that the patient underwent cataract surgery on his right eye on 02-FEB-2011 and subsequently developed dendritic keratitis in the right eye. The patient was seen for an evaluation in the physician's office on 10-MAR-2011. The physician stated that the patient responded well to stopping his topical steroid and that he had been treated with ZIRGAN 5 times a day for the past week. The physician gave the patient an eye exam which showed his vision had improved from 20/50 to 20/20. There was a small healing line on his cornea but no true dendrite and no inflammatory signs. The patient was to stop all his medication except for XALATAN and to return to the doctor if he had any reoccurrence of corneal issues. Subsequently it was reported that on 10-MAR-2011 the patient recovered (conflicting date on 09-MAR-2011 was reported). The patient felt that he had an allergic reaction to the drops status post cataract surgery. The doctor stated that although the cataract surgery and dentritic keratitis occurred soon after the ZOSTAVAX (Merck) was administered he was not certain that these were a related phenomenon. All available medical records will be provided up request. Additional information is not expected.
Sex: F
Vaccine: VARZOS
Symptoms: Injection site pain
Clinical narrative: Information has been received from a registered pharmacist concerning a female patient who on 15-APR-2011 was vaccinated with a dose of ZOSTAVAX (Merck) (lot number 667610/1355Z). The registered pharmacist reported that on 15-APR-2011 the patient experienced shoulder pain. The shoulder pain was in the same arm that the ZOSTAVAX was administered. The patient sought unspecified medical attention. It was unspecified if any treatment was given for the adverse event or any lab diagnostic studies were performed. At the time of the report, the patient's outcome was unknown. No further information is available.
Age: 60.0
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a registered nurse concerning a 60 year old male patient who on 04-APR-2011 was vaccinated SQ with a 0.65ml dose of ZOSTAVAX (Merck) (lot number not provided). The nurse reported that 9 days later, on 13-APR-2011, the patient was diagnosed with shingles in the physician's office. It was unspecified if the patient was given any treatment for the adverse event, or if any lab diagnostic tests were performed. At the time of the report, the patient's outcome was unknown. Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Injection site haematoma
Clinical narrative: Information has been received from a registered pharmacist concerning a female patient who on an unspecified date was vaccinated with a dose of ZOSTAVAX (Merck). On an unspecified date the patient experienced an injection site bruise. At the time of report the patient's status was unknown. Additional information has been requested. This is one of several reports from the same source.
Age: 76.0
Sex: F
Vaccine: VARZOS
Symptoms: Blood pressure increased, Flushing, Headache
Clinical narrative: Information has been received from a Doctor of pharmacy concerning a 76 year old female patient with hypothyroidism and hypertension and no allergies or drug reactions who on 14-APR-2011, was vaccinated with a dose of ZOSTAVAX (Merck) 0.65 ml, subcutaneously in the left arm (lot number 670385/0232AA, Exp. 16-MAY-2012). Concomitant therapy included LIPITOR, nifedipine, furosemide and SYNTHROID. The pharmacist reported that 10 minutes following the injection, the patient started to experience a headache and the patient's face became "flushed". The pharmacist reported that the patient's blood pressure was elevated at 142/80. The patient was given a cup of cold water and the patient has been observed in the pharmacy. The pharmacist mentioned that if the patient's headache and facial flushing did not resolve, the pharmacist "will refer the patient for medical evaluation". The patient did not receive any treatment for the event. There was no laboratories performed. At the time of the report the outcome of the patient was unknown. Additional information has been requested.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Laboratory test
Clinical narrative: Information has been received from a certified nurse practitioner concerning herself, a 60 year old female with seasonal allergy and a history of hysterectomy who in September or October in 2009, was vaccinated with a dose of ZOSTAVAX (Merck). Concomitant therapy included "PROVIDUAL" DYAZIDE, LIPITOR, ALLEGRA, estradiol, aspirin and vitamins (unspecified). In November 2009, the patient experienced multiple episodes of shingles after getting the ZOSTAVAX vaccine. She regretted getting the vaccine, also stated that might be the tech injected too much medicine in the vaccine. There was unspecified lab diagnostics studies performed in October 2010 (last fall). The patient sought unspecified medical attention. The patient was treated with acacia, neomycin, gentamicin. At the time of the report, the patient had not recovered from her adverse events. The patient sought unspecified medical attention. Additional information has been requested.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site haematoma, Injection site urticaria, Rash vesicular
Clinical narrative: Information has been received from a nurse practitioner concerning a 60 year old female with a history of drug allergies to clindamycin who on 14-MAR-2011 was vaccinated SC in the left arm with a 0.65 ml dose of ZOSTAVAX (Merck) (Lot number: 667610/1355Z; expiration date: 26-OCT-2011). Concomitant therapy included DHEA and "hormone cream" (manufacturer unknown). On 14-MAR-2011 (also reported as "24 hours after administration") the patient developed a "red welt" at injection site which tapered to a red area that looks like "a bruise". 3 weeks after vaccination, on approximately 04-APR-2011, the patient developed a varicella like rash on her left buttocks which was treated with Acyclovir and cleared 4 days ago, on 10-APR-2011. The patient sought medical attention by visiting physician in office. Upon the time of the report, the patient was recovering. Additional information has been requested.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site discomfort, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Information has been received from a physician concerning a 61 year old female who on 06-APR-2011 was vaccinated with a dose of ZOSTAVAX (Merck) at a local pharmacy (not the physician's office). On 10-APR-2011, 4 days after the injection, the patient experienced injection site pain, a good deal of redness and swelling at the injection site. On 13-APR-2011, the injection site was still providing discomfort, redness and swelling and had steadily increase to be about the size of a half dollar at the injection site. It was noted that the injection site was at an atypical spot, and was almost at the arm pit on the underside of the arm which was unusual. The patient visited the physician's office and sought medical attention. Upon the time of the report, the patient's present status was unknown. This is an amended report. "Vaccinated at" and "Vaccine Purchased with" now read as "unknown" instead of blank. Additional information has been requested.
Age: 74.0
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster, Nausea, Pain, Rash
Clinical narrative: Information has been received from a consumer concerning her 74 year old husband with type 2 diabetes mellitus and VALTREX allergy who on 04-APR-2011 was vaccinated with a dose of ZOSTAVAX (Merck) (dose, route and Lot # not reported). Concomitant therapy included GLUCOPHAGE, TYLENOL, codeine and pain pills. The consumer stated her husband developed shingles after receiving the vaccine. He started with the pain on 06-APR-2011 and then on 08-APR-2011 he broke out with the rash. He had seen numerous doctors and was given VALTREX but it caused him nausea. The other doctors he saw provided him with pain killer and medication such asa TRAMADOLOR, codeine and TYLENOL to treat the nausea. There was no lab diagnostics studies performed. At the time of the report, the patient had not recovered. Additional information has been requested.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a nurse concerning a female "in her 70's" who on unspecified date was vaccinated SC with a dose of ZOSTAVAX (Merck) and got shingles three months after receiving the vaccine. The patient sought unspecified medical attention and was treated with "Anti-viral". At the time of the report, the outcome of the event was not reported. Additional information has been requested.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Condition aggravated, Depression, Frustration, Herpes zoster
Clinical narrative: Information has been received from a physician concerning a female patient in her 60's with previous history of shingles several times who on an unspecified date was vaccinated with a 0.65ml dose of ZOSTAVAX (Merck) (route and Lot # not reported). There was no concomitant medication. Since vaccination the patient had been developing shingles more frequently and more severely. On 07-APR-2011 the patient was seen in the physician's office with shingles located on her buttock. She received unspecified treatment. The patient was depressed and frustrated that she kept getting shingles. The patient was normally a healthy person with no history of cancer or immunosuppression. At the time of the report, the patient had not recovered. Additional information has been requested.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Pyrexia, Swelling
Clinical narrative: Information has been received from a physician concerning a 64 year old female who on unspecified date was vaccinated SC with single 0.65ml dose of ZOSTAVAX (Merck). There was no concomitant medications. In March 2011, "within the last month", the patient experienced major swelling and developed a 102 degree Fahrenheit fever for 4 days. The patient sought unspecified medical attention and was administered ZOVIRAX after swelling and complications had resided. The patient's events subsided after 4 days and had recovered on 06-APR-2011. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Condition aggravated, Fibromyalgia
Clinical narrative: Information has been received from a physician concerning a patient with fibromyalgia who on an unknown date was vaccinated in the arm with a dose of ZOSTAVAX (Merck) (Lot # and expiration not reported). Physician reported that after vaccination with ZOSTAVAX the patient continued to complain of fibromyalgia (date unspecified). It was reported that the adverse event did not improved. The patient sought unspecified medical attention. At the time of reporting the patient's outcome was unknown. Additional information has been requested.
Sex: M
Vaccine: VARZOS
Symptoms: Headache, Muscle twitching, Paraesthesia oral
Clinical narrative: Information has been received from a pharmacist concerning a male with a pacemaker and other medical history unknown who on approximately 29-MAR-2011, "1 week ago", was vaccinated with a dose of ZOSTAVAX (Merck) (dose, route and lot# not reported). On approximately 29-MAR-2011, "1 week ago", the patient experienced headache and tingling or twitching on the upper lip. The patient made a phone call to seek medical attention. No treatment was given for the events. At the time of the report, the patient had not recovered. Additional information has been requested.
Age: 74.0
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster, Herpes zoster ophthalmic
Clinical narrative: Information has been received from a registered nurse concerning a 74 year old male patient with hypothyroidism and asthma, a history of deep vein thrombosis and no drug reactions/allergies, who on 30-JUN-2010 was vaccinated with a dose of ZOSTAVAX (Merck) subcutaneously (Lot number 664669/0152Z). Concomitant therapy included levothyroxine, MOTRIN, SPIRIVA and COUMADIN. The nurse reported that on 25-FEB-2011 the patient broke out in shingles in the right side of the face and in the right eye. Acyclovir was given as a treatment for the experience. On 06-APR-2011 the patient recovered from shingles. The patient sought unspecified medical attention. Additional information has been requested.
Sex: M
Vaccine: VARZOS
Symptoms: Rash
Clinical narrative: Information has been received from a male patient who on 30-MAR-2011 ("12 days ago") was vaccinated with ZOSTAVAX (Merck) (lot # not reported). Subsequently the patient experienced a rash, but not at the injection site. At the time of reporting, the patient's rash persisted. It was unspecified if the patient had sought medical attention. No further information is available.
Age: 55.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site rash, Rash erythematous
Clinical narrative: Information has been received from a Doctor of pharmacy concerning a 55 year old female patient with "something about her brain" and no drug reactions or allergies, who on 01-APR-2011, was vaccinated with a dose of ZOSTAVAX (Merck), 0.65 ml, subcutaneously in the left arm, (lot # 669259/1360Z, expiration date: 15-JAN-2012). On 02-APR-2011, the patient called the pharmacy to report that she developed a rash on her left arm at the injection site. Also, pharmacist reported that the patient reported that the rash "looks like shingles" and the rash was "pretty big" and red, but the rash was not itchy. The patient took unspecified doses of BENADRYL (manufacturer unknown) to treat the rash. The pharmacist reported that the patient called the pharmacy again on 03-APR-2011, and the patient stated that she would go to the pharmacy to show the rash on 04-APR-2011 but the patient had not gone to the pharmacy yet. No lab diagnostics were performed. At the time of the report, the patient had not recovered. Additional information has been requested.
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain in extremity
Clinical narrative: Information has been received from a pharmacist concerning a 72 year old female patient with no drug reactions or allergies who on 25-MAR-2011 was vaccinated SC in left arm with a 0.65ml dose of ZOSTAVAX (Merck) (lot # 667609/1354Z, exp: 26-OCT-2011). Subsequently the patient had been experiencing pain of her left arm. There was no swelling. There was no laboratory diagnostics studies performed. There was no treatment given for the adverse event. At the time of reporting, the patient had not recovered. The patient called the pharmacist to seek medical attention. Additional information has been requested.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a doctor of pharmacy concerning a 66 year old female patient with no outbreak and was not on any antivirals with a history of cold sore presented before getting ZOSTAVAX (Merck), who on 05-JUL-2010 was vaccinated with a 0.65 ml dose of ZOSTAVAX (Merck) (Lot number 664673/0150Z) subcutaneously in her left arm. The doctor of pharmacy reported that in February 2011, seven months after vaccination, the patient experienced shingles on the right side of her face. The patient was treated with valacyclovir hydrochloride, 1gm, three times a day was given when was an another city. Subsequently, the patient recovered. Then it was reported that just last week, in April 2010 the patient now had shingles on the other side of her face (also reported as right side of the face). No labs diagnostics were performed. Valacyclovir hydrochloride, 1gm, three times a day was given as a treatment for the experience. The patient was seen at physician's office for the recent bout of shingles. At the time of the report, the patient's outcome was unknown. This is one of several reports from the same source. Additional information has been requested.
Age: 77.0
Sex: M
Vaccine: VARZOS
Symptoms: Injection site erythema
Clinical narrative: Information has been received from a registered pharmacist (R. Ph) concerning a 77 year old male patient who on 04-APR-2011, was vaccinated with a dose of ZOSTAVAX (Merck), 0.65 ml, (lot number and site of administration not reported). On 07-APR-2011, the patient developed redness at injection site. It was unspecified if the patient sought medical attention. At the time of the report, the patient had not recovered. Additional information has been requested.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Contusion, Inflammation
Clinical narrative: Information has been received from a pharmacist concerning a 67 year old female who on unspecified date was vaccinated with a dose of ZOSTAVAX (Merck) in her shoulder. On unspecified dates, the patient's shoulder was very bruised and inflamed and it was possibly infected. The patient asked about the shoulder where her physician had administered ZOSTAVAX (Merck). The pharmacist believed the adverse experience might be due to how ZOSTAVAX (Merck) was administered to the patient. At the time of the report, the outcome was unknown. Additional information is not expected.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site discolouration, Injection site pain, Injection site swelling
Clinical narrative: Information has been received from a 60 year old female registered nurse, with no pertinent medical history and no known drug reactions or allergies, who on 07-JUN-2010, was vaccinated subcutaneously with a "single dose" of ZOSTAVAX (Merck) (Lot number 663333/1555X) (Expiration date 28-APR-2010). There was no concomitant medication. On 07-JUN-2010, the patient experienced soreness at the injection site, black and blue area at the injection site and swollen area at the injection site. The patient did not seek medical attention. No lab diagnostics studies were performed. At the time of reporting, the patient was recovering. Follow up information has been received from a physician. It was reported that in the morning of 07-JUN-2010 the 60 year old (also reported as 59 year old) nurse was vaccinated in the right deltoid with a first dose of ZOSTAVAX (Merck) (Lot number 663893/0128Y) (previously reported as lot number 663333/1555X). There was no illness at the time of vaccination. The physician reported that the patient's right deltoid got black and blue. On 20-JUN-2010 the patient recovered from right deltoid black and blue. No further information is expected.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a caller concerning a patient who on an unknown date was vaccinated with a dose of ZOSTAVAX (Merck). On an unspecified date the patient experienced shingles after receiving ZOSTAVAX (Merck). It was unknown if the patient sought medical attention. At the time of the report, the patient's status was unknown. No further information is available.
Age: 75.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a physician concerning a 75 year old female with no diabetes or any underlying disease who "over two years ago" in approximately 2008 was vaccinated with a dose of ZOSTAVAX (Merck) (lot # not reported). Subsequently the patient developed prominent zoster on her trunk. At the time on the report the patient's outcome was unknown. Additional information has been requested.